Company intelligence / Profile preview

Coredio

Ownership: Private
Development stage: Preclinical

Overview

Coredio has developed a non-invasive cardiac monitoring SaaS platform that provides real-time central blood pressure, cardiac output, arterial wall displacement, and other core cardiovascular signals using wearable sensors. The system is designed to aid cardiologists in tracking patient progress and optimizing medication titration. It aims to reduce unplanned hospital admissions/readmissions by enabling earlier intervention without the need for invasive procedures or specialist equipment. Clinical results emphasize improved workflow efficiency and accessibility of advanced diagnostics at the point of care

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware as a Service (SaaS)AI-assisted digital twin technology
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Coredio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coredio.

Explore the full profile